Skip to content
Clinical Trials – home

Hospital Universitario De Canarias

Verifiedinfo

Spain Carretera Ofra S/N, 38320 La Laguna, Spain

  • 43 trials recruiting
  • Breast cancer · Soft tissue sarcoma · HER2 positive breast cancer
  • Adults and children

About Specializations

Hospital Universitario De Canarias in La Laguna, Spain specialises in clinical trials of conditions such as Breast cancer, Soft tissue sarcoma, HER2 positive breast cancer, Breast cancer metastatic, and other specialisations. This site conducts important research.

Main research areas of the site

Immune System Diseases Research at Hospital Universitario De Canarias

The site is conducting clinical trials in immune system diseases, with a focus on Sjogren's syndrome. This research is aimed at better understanding the condition and evaluating new treatment options that may help improve symptoms and disease control for people living with this chronic autoimmune disorder.

  • Studying Sjogren's syndrome to assess whether new therapies can improve overall disease activity and patient outcomes.
  • Evaluating treatment effectiveness in autoimmune disease care, with attention to symptom relief and disease management.

These trials reflect a strong interest in advancing care for autoimmune conditions through more effective and targeted treatment strategies.

Nutritional and Metabolic Diseases Research in Kidney Transplantation

Clinical research at this hospital also covers nutritional and metabolic diseases, especially metabolic syndrome in patients waiting for kidney transplantation. The trials are exploring ways to improve metabolic health before transplant and reduce the risk of later complications such as diabetes.

  • Focusing on metabolic syndrome in transplant candidates to see whether treatment can help reverse abnormal metabolic changes before surgery.
  • Investigating GLP-1 receptor agonists as a preventive approach to support better metabolic control and lower the chance of post-transplant diabetes.

This area of research combines nephrology and metabolic care, with the goal of improving readiness for transplantation and long-term health outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Carretera Ofra S/N38320 La LagunaSpain
Recruiting now
43 trials
Conditions studied
95
Partner status
Verified

More sites in La LagunaSpain

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

123 clinical trials

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Zasocitinib
  • Sponsor:Takeda Development Center Americas Inc.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:BNT327
  • Sponsor:BioNTech SE
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Sargramostim
  • Sponsor:Greenwich LifeSciences Inc.
Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Emtricitabine
  • Sponsor:Novartis Pharma AG
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Seagen Inc.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Abacavir
  • Sponsor:Gilead Sciences Inc.
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Cabozantinib
  • Sponsor:Institut Gustave Roussy
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Prednisone
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Bexmarilimab
  • Sponsor:Medica Scientia Innovation Research S.L.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Boehringer Ingelheim Espana S.A.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.